⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20248298 | 0.74 | — | — | |
| SCHEMBL14351697 | 0.69 | — | — | |
| SCHEMBL6717384 | 0.69 | — | — | |
| SCHEMBL491309 | 0.67 | — | — | |
| SCHEMBL10629180 | 0.67 | — | — | |
| SCHEMBL14351696 | 0.67 | — | — | |
| SCHEMBL6717388 | 0.67 | — | — | |
| SCHEMBL8182345 | 0.65 | — | — | |
| SCHEMBL16886048 | 0.63 | — | — | |
| SCHEMBL10146072 | 0.63 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11267801-B2 | Therapeutic compounds | GILEAD SCIENCES, INC. (US) | 2022-03-08 | — | — | US | disclosed |
| US-20210171498-A1 | THERAPEUTIC COMPOUNDS | GILEAD SCIENCES, INC. | 2021-06-10 | — | — | US | disclosed |